Sirtris Pharmaceuticals Presents Results of Studies of SIRT1 Activators - Sirtris - Inv... - 0 views
-
Matti Narkia on 06 Aug 09Dr. Milne presented data which showed that SRT501, Sirtris' proprietary formulation of resveratrol, reduces glucose and improves insulin sensitivity in multiple pre-clinical models of Type 2 Diabetes. Dr. Milne also presented pharmacokinetic (PK) data fro